Tag: Dr. Kenneth Ataga

Clinical Trial Led by UTHSC’s Kenneth Ataga, MD, Results in FDA Approval of New Sickle Cell Treatment


Patients with sickle cell disease will soon have a new treatment option to reduce pain crises caused by obstructed blood flow. The FDA has approved use of the drug crizanlizumab based on the results of a clinical trial led by Kenneth Ataga, MD, Plough Foundation Endowed Chair in Sickle Cell Disease and director of the… Read More

UTHSC Hosts Impressive Roster of Sickle Cell Researchers at 2019 Norfleet Forum


Clinicians and researchers from around the country gathered in Memphis Friday for the 2019 Frank M. Norfleet Forum for the Advancement of Health to discuss sickle cell disease research and treatment. They looked back at how the disease has developed over the last century and what the future holds for those born with it and… Read More